FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Mixed Decision in a Preemption Case

Attorney Michelle Yeary says a Tennessee federal court dismissed many parts of a failure-to-warn case against Boehringer Ingelheim over injuries alleg...

Medical Devices

Dual 510(k) CLIA Waiver Guidance

FDA issues a draft guidance leveraging its experience in implementing the MDUFA 3 Dual 5120(k) and CLIA Waiver by Application pathway.

Human Drugs

CGMP Violations at Koreas Dae Young Foods

FDA warns South Koreas Dae Young Foods Company about CGMP and misbranding violations in its work as a contractor manufacturing finished pharmaceutical...

Human Drugs

Sentinel Role in Drug Safety Defended

CDER Office of Surveillance and Epidemiology deputy director Robert Ball describes the ways in which the agencys Sentinel System is being used and can...

FDA General

FDA Has Most of HHS Withdrawn Regulations: Survey

A Public Citizen analysis of 457 rulemakings withdrawn by the Trump administration finds that 26 were from FDA, the highest number of any HHS agency.

Human Drugs

Draft Guide on CLIA Waivers

FDA posts a draft guidance on Select Updates for Recommendations for Clinical Laboratory Improvement Amendments of 1988 (CLIA) Waiver Applications for...

Human Drugs

FDA Adds Patent Submission Dates to Orange Book

Two Hyman, Phelps attorneys say FDA is helping generic drug applicants by starting to list patent submission dates in the Orange Book.

Human Drugs

FDA Guide on Pediatric Info in X-ray 510(k)s

Federal Register notice: FDA makes available a guidance entitled Pediatric Information for X-ray Imaging Device Premarket Notifications.

Human Drugs

FDA Reducing Hurdles for Generic Complex Drugs: Gottlieb

Commissioner Scott Gottlieb says FDA ramps up its efforts to improve the process for developing generic copies of complex drugs.

Medical Devices

Safety Alert on Biotin Affecting Lab Testing

An FDA safety alert warns that dietary supplements containing biotin (vitamin B7) can cause clinically significant incorrect lab test results.